Resumen

HERNANDEZ FERNANDEZ, Yardanis et al. Current therapies in corneal vascularization. Rev Cubana Oftalmol [online]. 2021, vol.34, n.1  Epub 01-Mar-2021. ISSN 1561-3070.

A clear cornea is essential for excellent vision; that is why it is avascular. But there are conditions that favor the invasion of neovessels into the corneal tissue, such as infections, inflammation, hypoxia, trauma, among others, which reduce visual quality and in some cases even lose it. Corneal neovascularization represents a major public health problem worldwide. An automated search was carried out in order to find updated information on the treatment of corneal neovascularization, for which the infomed platform was used. The information was summarized in the final document. On the subject, there is notable progress in understanding the pathogenesis, improvement and safety of new treatments. Corticosteroids and anti-VEGF (vascular endothelial growth factor) agents continue to be the first-line drugs, used mainly to prevent the formation of new vessels, not for mature vessels, where the best option is surgical or combined procedures. More experimental studies are needed; and the existing ones should be used in clinical trials to investigate the safe dose and side effects, and thus find radical and more effective therapies that give patients with corneal neovascularization the hope of better visual quality.

Palabras clave : Corneal vascularization; Pharmacotherapy; laser, surgical.

        · resumen en Español     · texto en Español     · Español ( pdf )